Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma
Clinical trial NCT06216158 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06216158
- Sponsor
- University of Heidelberg Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-05
- Primary completion
- 2028-12-01
- Enrollment
- 411
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.